Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/28099
DC FieldValueLanguage
dc.contributor.authorFilip Djokoski,en_US
dc.contributor.authorHiljadnikova bajro, Marijaen_US
dc.date.accessioned2023-10-04T12:38:09Z-
dc.date.available2023-10-04T12:38:09Z-
dc.date.issued2023-
dc.identifier.citationDjokoski F. Hiljadnikova-Bajro M., The Impact of the Human Microbiome on Cancer Immunotherapy, Macedonian pharmaceutical bulletin, 2023: 69 (Suppl 1) 271 - 272en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12188/28099-
dc.language.isoenen_US
dc.publisherMacedonian Pharmaceutical Associationen_US
dc.relation.ispartofMacedonian pharmaceutical bulletin, 69 (Suppl 1) 271 - 272 (2023)en_US
dc.subjectmicrobiota, microbiome, immunotherapy, canceren_US
dc.titleThe Impact of the Human Microbiome on Cancer Immunotherapyen_US
dc.typeJournal Articleen_US
dc.relation.conference14th Central European Symposium on Pharmaceutical Technology, September 28-30, 2023 Ohrid, N. Macedoniaen_US
dc.identifier.doiDOI:10.33320/maced.pharm.bull.2023.69.03.132-
dc.identifier.eissn1857 - 8969-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Pharmacy-
Appears in Collections:Faculty of Pharmacy: Journal Articles
Прикажи едноставен запис

Page view(s)

93
checked on 4.5.2025

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.